Ajou University repository

Epidemiology, comorbidities, and prescription patterns of Korean Prurigo nodularis patients: A multi-institution studyoa mark
Citations

SCOPUS

27

Citation Export

Publication Year
2022-01-01
Publisher
MDPI
Citation
Journal of Clinical Medicine, Vol.11
Keyword
ComorbiditiesEpidemiologyKoreaPrescription patternPrurigo nodularis
All Science Classification Codes (ASJC)
Medicine (all)
Abstract
Prurigo nodularis (PN) is a chronic dermatosis typified by extraordinarily itchy nodules. However, little is known of the nature and extent of PN in Asian people. This study aimed to describe the epidemiology, comorbidities, and prescription pattern of PN in Koreans based on a large dermatology outpatient cohort. Patients with PN were identified from the Catholic Medical Center (CMC) clinical data warehouse. Anonymized data on age, sex, diagnostic codes, prescriptions, visitation dates, and other relevant parameters were collected. Pearson correlation analysis was used to calculate the correlation between PN prevalence and patient age. Conditional logistic regression modeling was adopted to measure the comorbidity risk of PN. A total of 3591 patients with PN were identified at the Catholic Medical Center Health System dermatology outpatient clinic in the period 2007–2020. A comparison of the study patients with age-and sex-matched controls (dermatology outpatients without PN) indicated that PN was associated with various comorbidities including chronic kidney disease (adjusted odds ratio (aOR), 1.48; 95% confidence interval (CI), 1.29–1.70), dyslipidemia (aOR, 1.88; 95% CI, 1.56–2.27), type 2 diabetes mellitus (aOR, 1.37; 95% CI, 1.22–1.54), arterial hypertension (aOR, 1.50; 95% CI, 1.30–1.73), autoimmune thyroiditis (aOR, 2.43; 95% CI, 1.42–4.16), non-Hodgkin’s lymphoma (aOR, 1.95; 95% CI, 1.23–3.07), and atopic dermatitis (aOR, 2.16, 95% CI, 1.91–2.45). Regarding prescription patterns, topical steroids were most favored, followed by topical calcineurin inhibitors; oral antihistamines were the most preferred systemic agent for PN. PN is a relatively rare but significant disease among Korean dermatology outpatients with a high comorbidity burden compared to dermatology outpatients without PN. There is great need for breakthroughs in PN treatment.
ISSN
2077-0383
Language
eng
URI
https://dspace.ajou.ac.kr/dev/handle/2018.oak/32446
DOI
https://doi.org/10.3390/jcm11010095
Fulltext

Type
Article
Funding
Funding: This study was supported by Trevi Therapeutics, the National Research Foundation of Korea (NRF) grant funded by the South Korean Government (grant number: 2020R1F1A1048238), and the Institute of Information and Communications Technology Planning and Evaluation (IITP) grant funded by the Korea Government (MSIT) (Artificial Intelligence Innovation Hub) (grant number: 2021-0-02068).
Show full item record

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Sohn, Kyung-Ah Image
Sohn, Kyung-Ah손경아
Department of Software and Computer Engineering
Read More

Total Views & Downloads

File Download

  • There are no files associated with this item.